Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Kazangyan_Lilit_1000x714_ENV

Lilit Kazangyan

Special Counsel

Los Angeles +1 424 332 4769

  • About
  • Representative Matters
  • Credentials
  • About

    Lilit Kazangyan represents investment banks as well as public and private companies in connection with a variety of domestic and international capital markets transactions, including initial public offerings, follow-on offerings, and high-yield and investment grade debt offerings. Lilit has significant experience in capital market financings by special purpose acquisition companies (SPACs). She also advises clients on general corporate matters, including securities laws compliance and corporate governance.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Represented the underwriters or issuer in various initial public offerings by SPACs, including those of Crescent Acquisition Corp, Tortoise Acquisition Corp., AMCI Acquisition Corp., ARYA Sciences Acquisition Corp., Leo Holdings Corp., Leisure Acquisition Corp., Osprey Energy Acquisition Corp., and Hennessy Capital Acquisition Corp. III. 
    • Represented the underwriters in the initial public offering of Codex DNA, Inc., a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build high-quality synthetic DNA and mRNA.
    • Represented the underwriters in the initial public offering and subsequent follow-on offering of NeuroDerm Ltd., an Israel-based clinical-stage biopharmaceutical company focused on treatments for central nervous system disorders.
    • Represented the underwriters in the initial public offering and subsequent follow-on offering of Affimed N.V., a German-based clinical-stage biotechnology company focused on cancer immunotherapies.
    • Represented the underwriters in the initial public offering and subsequent follow-on offering of uniQure N.V., a Netherlands-based biotechnology company focused on gene therapies.

    • Represented the underwriter in the initial public offering of Presbia PLC, an Ireland-based ophthalmic device company marketing an optical lens implant for treating presbyopia.
    • Represented the underwriters in the initial public offering of OncoMed Pharmaceuticals, Inc., a U.S.-based clinical-stage biopharmaceutical company developing antibody therapeutics targeting cancer stem cells.
    • Represented the underwriters or issuer in various follow-on equity offerings, including those of BioNTech SE, Compugen Ltd., Spirit of Texas Bancshares, Inc., and Veru Inc.
    • Represented the underwriters or issuer in various follow-on debt offerings, including those of BancorpSouth Bank, Fidelity National Information Services, Inc., O’Reilly Automotive, Inc., and Veritex Holdings, Inc.
    • Represented the sponsor in connection with the corporate finance aspects of acquisition transactions, including the $1.1 billion offering of high-yield notes and the $515 million offering of high-yield notes by two of its portfolio companies.
    • Represented the sales agent in various at-the-market offerings, including those of Bicycle Therapeutics plc, Erytech Pharma S.A., Theravance Biopharma, Inc., and UroGen Pharma Ltd.

    Areas of Expertise

  • Credentials
    Education
    • Columbia Law School, J.D., 2010
        • Columbia Journal of European Law, Online Production Editor
        • Columbia Journal of East European Law, Staff Editor
    • Stanford University, B.A./M.A., 2007
    Bar Admissions
    • California
    • New York
    Languages
    • Armenian
    Accolades

    Areas of Expertise

News and Insights

Events